Pulmonary hypertension in rheumatic diseases: Epidemiology and pathogenesis

Rheumatology International

Volumn 33, Issue 7, 2013, Pages 1655-1667

  Shahane, Anupama ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Connective tissue disease; Pulmonary hypertension; Rheumatic diseases; Scleroderma

Indexed keywords

CARDIOLIPIN ANTIBODY; CORTICOSTEROID; ILOPROST; IMMUNOSUPPRESSIVE AGENT; PHOSPHOLIPID ANTIBODY; PROSTACYCLIN; TREPROSTINIL;

ANKYLOSING SPONDYLITIS; ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING DISORDER; CONNECTIVE TISSUE DISEASE; DERMATOMYOSITIS; DISEASE ASSOCIATION; DISEASE COURSE; HUMAN; IMMUNOMODULATION; IMMUNOSUPPRESSIVE TREATMENT; LUNG FIBROSIS; MICROTHROMBUS; MIXED CONNECTIVE TISSUE DISEASE; MYOSITIS; PATHOGENESIS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; PULMONARY VASCULITIS; REVIEW; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; SARCOIDOSIS; SCLERODERMA; SJOEGREN SYNDROME; SPONDYLOARTHROPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; VASCULITIS; VEIN OCCLUSION;

ANIMALS; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION, PULMONARY; IMMUNOSUPPRESSIVE AGENTS; RHEUMATIC DISEASES; RISK FACTORS; TREATMENT OUTCOME; VASODILATOR AGENTS;

EID: 84879687991     PISSN: 01728172     EISSN: 1437160X     Source Type: Journal    
DOI: 10.1007/s00296-012-2659-y     Document Type: Review

References (11)

1. Chatterjee S (2011) Pulmonary hypertension in systemic sclerosis. Semin Arthritis Rheum 41(1):19-37
2. Agarwal R, Gomberg-Maitland M (2011) Current therapeutics and practical management strategies for pulmonary arterial hypertension. Am Heart J 162(2):201-213
3. Distler O, Pignone A (2006) Pulmonary arterial hypertension and rheumatic diseases-from diagnosis to treatment. Rheumatology (Oxford) 45(Suppl 4):iv22-iv25
4. Fisher MR, Mathai SC, Champion HC, Girgis RE, Housten-Harris T, Hummers L et al (2006) Clinical differences between idiopathic and scleroderma-related pulmonary hypertension. Arthritis Rheum 54(9):3043-3050
5. Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC), European Respiratory Society (ERS), International Society of Heart and Lung Transplantation (ISHLT), Galie N, Hoeper MM, Humbert M et al (2009) Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J 34(6):1219-1263
6. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR et al (2009) ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 53(17):1573-1619
7. Steen VD, Medsger TA (2007) Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 66(7):940-944
8. Condliffe R, Kiely DG, Peacock AJ, Corris PA, Gibbs JS, Vrapi F et al (2009) Connective tissue disease-associated pulmonary arterial hypertension in the modern treatment era. Am J Respir Crit Care Med 179(2):151-157
9. Lambova S, Muller-Ladner U (2010) Pulmonary arterial hypertension in systemic sclerosis. Autoimmun Rev 9(11):761-770
10. Pope JE, Lee P, Baron M, Dunne J, Smith D, Docherty PS et al (2005) Prevalence of elevated pulmonary arterial pressures measured by echocardiography in a multicenter study of patients with systemic sclerosis. J Rheumatol 32(7):1273-1278
11. Wigley FM, Lima JA, Mayes M, McLain D, Chapin JL, Ward-Able C (2005) The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary h